
Key Policy Updates from the Office of Public Affairs
The bulletin below from the Office of Public Affairs is intended to raise awareness of key policy updates and events as we head into the new year. Please contact publicaffairs@asrm.org with any inquiries regarding the following items.
If you are interested in making a difference through advocacy, please fill out this form to share your information and interests in our advocacy efforts and stay involved as we work together to create a brighter future!
Fiscal Year 2025 National Defense Authorization Act Signed into Law
Annual Defense Authorization Bill Includes Fertility and Reproductive Health Care Provisions Supported and Opposed by ASRM
On December 23, President Joe Biden signed the Fiscal Year 2025 (FY25) National Defense Authorization Act (NDAA) into law. While the annual defense policy bill has been enacted for the past 65 consecutive years, in recent NDAA cycles, the bill’s title on military health care has made the NDAA a legislative vehicle for debates on reproductive health care.This year’s defense authorization process was no different, with the final FY25 NDAA conference report including certain policy provisions that were supported by and others that were opposed by the American Society for Reproductive Medicine (ASRM). Because the final FY25 NDAA conference negotiations resulted in both legislative victories, as well as misguided policy provisions and missed opportunities, ASRM remained neutral on the overall legislative package.
Throughout this year’s NDAA cycle, ASRM has been a leader and highly engaged in advocating for expanded access to fertility treatment and other reproductive health care for service members. ASRM supported the following provisions included in the final version of the recently enacted FY25 NDAA:
- Demonstration Program on Cryopreservation and Storage of Gametes for Members of the Armed Forces: The FY25 NDAA includes language authorizing a three-year demonstration program to reimburse service members for expenses incurred in the retrieval, testing, cryopreservation, shipping, and storage of gametes in a private storage facility.
- Contraception Coverage Parity Under TRICARE: After more than a decade of efforts to eliminate copays for contraception for military families, the final NDAA provision signed into law will end all cost-sharing for contraception under TRICARE immediately in perpetuity.
However, ASRM remains deeply concerned by NDAA policy decisions that continue to promote disparity and inequity in the fertility treatment and reproductive health care available to military families. Specifically, ASRM opposed Congress’:
- Failure to Expand TRICARE Coverage for In Vitro Fertilization (IVF): For the first time in any NDAA cycle, both the House and Senate FY25 defense authorization bills included expanded IVF coverage under TRICARE. For this reason, it is unusual that an IVF provision did not appear in the final NDAA agreement. By excluding this bipartisan and bicameral priority, Congress missed the opportunity to ensure that military families, who face higher rates of infertility than the general population, have the same access to IVF coverage that will become available to Members of Congress and Congressional staff beginning in January 2025.
- Prohibition on TRICARE Coverage of Gender-Affirming Care for Minors: The legislation signed into law includes a ban on TRICARE coverage of medical interventions for the treatment of gender dysphoria for transgender youth in military families.
Protecting and expanding access to fertility treatment and other reproductive health care for the men and women who serve our country should be easy and cost-effective because it is the right thing to do. ASRM looks forward to continuing to educate defense policymakers and to working alongside reproductive health care champions in Congress to enact smart and inclusive policies that maintain the readiness of the all-volunteer force, support the services in achieving their recruitment and retention goals, and as a result, bolster U.S. national security.
ASRM and Women First Research Coalition Advocate for Increased Funding for Women’s Health Research
ASRM is working with the Women First Research Coalition (WFRC) to advocate for increased funding for women’s reproductive research.
If you have stories or examples of successful NIH-funded research—be they basic, translational, or clinical—we would love to share them with policymakers. Please email your suggestions to publicaffairs@asrm.org.
Read our full statement here on the National Academies of Science, Engineering, and Medicine (NASEM)’s report “A New Vision for Women’s Health”.
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Fertility in the News

American Society for Reproductive Medicine Releases Fact Sheet on Biological Sex Differentiation
ASRM releases a new “Just the Facts” paper on biological sex, emphasizing scientific complexity and advocating for informed policymaking in reproductive medicine.

ASRM Government Affairs Manager Jessie Losch named Director of Government Affairs
Jessie Losch, an experienced advocate for reproductive medicine, has been named ASRM's Director of Government Affairs, starting February 1, 2025.
Find a Health Professional
